Terms ending in 2038
Every in-force patent on Ablynx N.V.'s record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,630,617 | Serum Albumin Binders In force · High confidence | Sanofi | In force | High confidence | |
| US 11,046,767 | T Cell Recruiting Polypeptides Based on CD3 Reactivity In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 11,414,481 | Serum Albumin Binders In force · High confidence | Sanofi | In force | High confidence | |
| US 11,414,480 | Improved Serum Albumin Binding Immunoglobulin Single Variable Domains In force · High confidence | Sanofi | In force | High confidence | |
| US 11,261,260 | Adamts Binding Immunoglobulins Ablynx N.V. and Sanofi In force · High confidence | Ablynx N.V. and Sanofi | In force | High confidence | |
| US 11,603,401 | Aggrecan Binding Immunoglobulins In force · High confidence | Merck Patent GmbH | In force | High confidence | |
| US 12,129,308 | MMP13 Binding Immunoglobulins In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 11,840,569 | T Cell Recruiting Polypeptides Capable of Binding CD123 and TCR Alpha/Beta In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 11,952,418 | Biparatopic Polypeptides Antagonizing WNT Signaling in Tumor Cells In force · High confidence | Boehringer Ingelheim International GmbH | In force | High confidence | |
| US 11,248,055 | Polypeptides Inhibiting CD40L In force · High confidence | Ablynx N.V. | In force | High confidence | |
| 2 more term ends in 2038 · Pro | |||||
10 of 12 patents shown. Soonest term end first, then patent number.
Pro members see all 12.
7 of these are in force and held by Ablynx N.V..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.